More info on which is currently listed on Brandbucket

Description : Discover the history with more useful stats and insights on the business name Divisor before purchasing the domain.

Product : Divisor is a brandable business domain name for sale for $14,995. It falls under the following categories: Financial, Operations, Organization .

Divisor is in the .com extension. TLDs may be used for diffrent purpose. Example: .com extension inherited from "commercial" and used for generally commercial activities, .net extension inherited from "network" and used for generally internet activites etc.

Image of Divisor

Social Media Availability:

Facebook social media handle is not available.

Twitter social media handle is not available.

Instagram social media handle is not available.

Youtube social media handle is available.

Last Updated: 3 months, 1 week ago

Categories related definition(s) :

Financial :
- involving financial matters
Operations :
- financial transactions at a brokerage; having to do with the execution of trades and keeping customer records
Organization :
- a group of people who work together
- an ordered manner; orderliness by virtue of being methodical and well organized

Domain Name :

Age : 14 Year(s) old

Price : $14,995

Domain Creation date : 2003-06-15

Domain Expiration date : 2019-06-15

Domain length : Divisor is 7 characters long. Character length is an important factor to ensure human readability, brand and seo friendliness. It must be less than 18 character long.

Brandbucket published date :2018-01-09


Registrant Country : US

Expand For More Info

Registrant Name : Whois Agent

Registrant Email : [enable javascript!]

Registrant Number : [enable javascript!]

Similar Companies Business Names

Domain name Company Name Market Artist Extract Mobile Games Divine Arts Film Distribution Subcommune Language Learning Divide Data Lead Generation Divine Intervention Software Data Mining Divisax P2P Money Transfer Divide Enterprise Software Dividom Crowdfunding Divinely Consumers Divine Universal Studies Therapeutics